Cross talk between Smad, MAPK, and Actin in the etiology of pulmonary arterial hypertension

Advances in Experimental Medicine and Biology

Volumn 661, Issue , 2010, Pages 265-278

  West, James ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone morphogenetic protein receptor; Genetics; Hypoxia; Inflammatory cells; Signal transduction

Indexed keywords

ACTIN; ANOREXIGENIC AGENT; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CHAPERONIN CONTAINING TCP1; HEMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIM KINASE 1; LIPOPOLYSACCHARIDE; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCROTALINE; PROTEIN TYROSINE KINASE; PYRROLIDINE DITHIOCARBAMATE; SMAD PROTEIN; SORAFENIB; VASCULOTROPIN;

APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; ENZYME INHIBITION; GENE MUTATION; HUMAN; HYPOXIA; INFLAMMATION; LIGHT CHAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PULMONARY HYPERTENSION; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALIA;

ACTINS; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NF-KAPPA B; RISK FACTORS; SIGNAL TRANSDUCTION; SMAD PROTEINS; SRC-FAMILY KINASES;

EID: 77951215757     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-500-2_17     Document Type: Conference Paper

References (47)

1. Deng Z, Morse JH, Slager SL et al (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67:737-744 (Pubitemid 30659603)
2. Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-b receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26:81-84
3. Thomson JR, Machado RD, Pauciulo MW et al (2000) Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-b family. J Med Genet 37:741-745
4. Tiedemann H, Asashima M, Grunz H, Knochel W (2001) Pluripotent cells (stem cells) and their determination and differentiation in early vertebrate embryogenesis. Dev Growth Differ 43:469-502 (Pubitemid 32953769)
5. Herpin A, Cunningham C (2007) Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J 274:2977-2985 (Pubitemid 46849089)
6. Nohe A, Keating E, Underhill TM, Knaus P, Petersen NO (2003) Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways. J Cell Sci 116:3277-3284 (Pubitemid 37038976)
7. Nishihara A, Watabe T, Imamura T, Miyazono K (2002) Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension. Mol Biol Cell 13:3055-3063 (Pubitemid 35034245)
8. Jeffery TK, Upton PD, Trembath RC, Morrell NW (2005) BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways. Am J Physiol Lung Cell Mol Physiol 288:L370-L378 (Pubitemid 40105376)
9. Rudarakanchana N, Flanagan JA, Chen H et al (2002) Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11:1517-1525 (Pubitemid 34679252)
10. Foletta VC, Lim MA, Soosairajah J et al (2003) Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 162:1089-1098 (Pubitemid 37174191)
11. Machado RD, Rudarakanchana N, Atkinson C et al (2003) Functional interaction between BMPR-II and Tctex-1, a light chain of dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertension. Hum Mol Genet 12:3277-3286 (Pubitemid 37541073)
12. Lu M, Lin SC, Huang Y et al (2007) XIAP induces NF-kB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell 26:689-702 (Pubitemid 46856243)
13. Wong WK, Knowles JA, Morse JH (2005) Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 33:438-446 (Pubitemid 41572686)
14. Newman JH, Phillips JA III, Loyd JE (2008) Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies. Ann Intern Med 148:278-283 (Pubitemid 351665488)
15. Lu MM, Yang H, Zhang L, Shu W, Blair DG, Morrisey EE (2001) The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev Dyn 222:667-680 (Pubitemid 33136337)
16. Morrell NW (2006) Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? Proc Am Thorac Soc 3:680-686 (Pubitemid 44788224)
17. Rajan P, Panchision DM, Newell LF, McKay RD (2003) BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 161:911-921 (Pubitemid 36718424)
18. Yanagisawa M, Nakashima K, Takizawa T, Ochiai W, Arakawa H, Taga T (2001) Signaling crosstalk underlying synergistic induction of astrocyte differentiation by BMPs and IL-6 family of cytokines. FEBS Lett 489:139-143 (Pubitemid 32126397)
19. Yamaguchi K, Nagai S, Ninomiya-Tsuji J et al (1999) XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 18:179-187 (Pubitemid 29005034)
20. Fuentealba LC, Eivers E, Ikeda A et al (2007) Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 131:980-993 (Pubitemid 350138081)
21. Winter-Vann AM, Johnson GL (2007) Integrated activation of MAP3Ks balances cell fate in response to stress. J Cell Biochem 102:848-858 (Pubitemid 350036925)
22. Li MG, Serr M, Newman EA, Hays TS (2004) The Drosophila tctex-1 light chain is dispensable for essential cytoplasmic dynein functions but is required during spermatid differentiation. Mol Biol Cell 15:3005-3014 (Pubitemid 38850099)
23. Sachdev P, Menon S, Kastner DB et al (2007) G protein bg subunit interaction with the dynein light-chain component Tctex-1 regulates neurite outgrowth. EMBO J 26:2621-2632 (Pubitemid 46884283)
24. Chuang JZ, Yeh TY, Bollati F et al (2005) The dynein light chain Tctex-1 has a dyneinindependent role in actin remodeling during neurite outgrowth. Dev Cell 9:75-86 (Pubitemid 40903661)
25. Baruzzi A, Caveggion E, Berton G (2008) Regulation of phagocyte migration and recruitment by Src-family kinases. Cell Mol Life Sci 65:2175-2190
26. Kuramochi Y, Guo X, Sawyer DB (2006) Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. J Mol Cell Cardiol 41:228-235 (Pubitemid 44080212)
27. Ghosh S, Hayden MS (2008) New regulators of NF-kB in inflammation. Nat Rev Immunol 8:837-848
28. West J, Harral J, Lane K et al (2008) Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am J Physiol Lung Cell Mol Physiol 295:L744-L755
29. West J, Fagan K, Steudel W et al (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ Res 94:1109-1114 (Pubitemid 38579706)
30. Tada Y, Majka S, Carr M et al (2007) Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH. Am J Physiol Lung Cell Mol Physiol 292:L1556-L1563 (Pubitemid 47077371)
31. Hagen M, Fagan K, Steudel W et al (2007) Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am J Physiol Lung Cell Mol Physiol 292:L1473-L1479 (Pubitemid 47077364)
32. Taraseviciene-Stewart L, Kasahara Y, Alger L et al (2001) Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15:427-438 (Pubitemid 32141434)
33. Tada Y, Laudi S, Harral J et al (2008) Murine pulmonary response to chronic hypoxia is strain specific. Exp Lung Res 34:313-323 (Pubitemid 351948463)
34. Dorfmuller P, Perros F, Balabanian K, Humbert M (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22:358-363 (Pubitemid 36987011)
35. Shimzu K, Takahashi T, Iwasaki T et al (2008) Hemin treatment abrogates monocrotalineinduced pulmonary hypertension. Med Chem 4:572-576
36. Klein M, Schermuly RT, Ellinghaus P et al (2008) Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. Circulation 118:2081-2090
37. Huang J, Kaminski PM, Edwards JG et al (2008) Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol Lung Cell Mol Physiol 294:L1250-L1259
38. West J, Cogan J, Geraci M et al (2008) Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics 1:45
39. MacLean MR (2007) Pulmonary hypertension and the serotonin hypothesis: where are we now. Int J Clin Pract Suppl 156:27-31 (Pubitemid 47174380)
40. Phillips JA III, Poling JS, Phillips CA et al (2008) Synergistic heterozygosity for TGFb1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet Med 10:359-365 (Pubitemid 351770407)
41. Remillard CV, Tigno DD, Platoshyn O et al (2007) Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol 292:C1837-C1853 (Pubitemid 47080568)
42. Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C (2005) The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 52:2125-2132 (Pubitemid 40994336)
43. Ihn H (2008) Autocrine TGF-b signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 49:103-113 (Pubitemid 350298736)
44. Straub RH (2007) The complex role of estrogens in inflammation. Endocr Rev 28:521-574 (Pubitemid 47236336)
45. Wagenvoort CA, Wagenvoort N, Draulans-Noe Y (1984) Reversibility of plexogenic pulmonary arteriopathy following banding of the pulmonary artery. J Thorac Cardiovasc Surg 87:876-886 (Pubitemid 14084669)
46. Bellotto F, Chiavacci P, Laveder F, Angelini A, Thiene G, Marcolongo R (1999) Effective immunosuppressive therapy in a patient with primary pulmonary hypertension. Thorax 54:372-374 (Pubitemid 29150169)
47. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M (2006) Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130:182-189 (Pubitemid 44116858)